CHIMERIX INC
DelistedCIK 1117480fmd_1MNJF291G8GQK163EWCMYN5EE0Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2011 to Dec 31, 2024, 53 periods
Latest annual · FY2024
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (97)
- Net income
- (88)
- Free cash flow
- (75)
Latest quarter · Q4 FY2024
Millions- Total revenues
- 0
- Operating income
- (25)
- Net income
- (23)
- Free cash flow
- (19)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2021 to FY2024
- -52.5%
- Revenue, 5 yearsFY2019 to FY2024
- -55.8%
- Net income, 5 yearsFY2019 to FY2024
- n/m
CHIMERIX INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Revenue | $212,000 | $324,000 | -34.6% | 10-K 2025-03-21 · proof |
| Gross profit | $212,000 | $324,000 | -34.6% | 10-K 2025-03-21 · proof |
| Operating income | -$96.6 million | -$93.1 million | 10-K 2025-03-21 · proof | |
| Net income | -$88.4 million | -$82.1 million | 10-K 2025-03-21 · proof | |
| Cash from operating activities | -$75 million | -$69.1 million | 10-K 2025-03-21 · proof | |
| Free cash flow | -$75.3 million | -$69.2 million | 10-K 2025-03-21 · proof | |
| Total assets | $146 million | $212.8 million | -31.4% | 10-K 2025-03-21 · proof |
| Total liabilities | $24.3 million | $19.7 million | +23.2% | 10-K 2025-03-21 · proof |
| Cash and cash equivalents | $31 million | $27.7 million | +12.2% | 10-K 2025-03-21 · proof |
- What was CHIMERIX INC's revenue in fiscal 2024?
- CHIMERIX INC reported revenue of $212,000 for fiscal 2024 (the year ended Dec 31, 2024), against $324,000 the year before (-34.6%). Source: the 10-K filed with the SEC on Mar 21, 2025. SEC
- What was CHIMERIX INC's gross profit in fiscal 2024?
- CHIMERIX INC reported gross profit of $212,000 for fiscal 2024 (the year ended Dec 31, 2024), against $324,000 the year before (-34.6%). Source: the 10-K filed with the SEC on Mar 21, 2025. SEC
- What was CHIMERIX INC's operating income in fiscal 2024?
- CHIMERIX INC reported operating income of -$96.6 million for fiscal 2024 (the year ended Dec 31, 2024), against -$93.1 million the year before. Source: the 10-K filed with the SEC on Mar 21, 2025. SEC
- What was CHIMERIX INC's net income in fiscal 2024?
- CHIMERIX INC reported net income of -$88.4 million for fiscal 2024 (the year ended Dec 31, 2024), against -$82.1 million the year before. Source: the 10-K filed with the SEC on Mar 21, 2025. SEC
- What was CHIMERIX INC's cash from operating activities in fiscal 2024?
- CHIMERIX INC reported cash from operating activities of -$75 million for fiscal 2024 (the year ended Dec 31, 2024), against -$69.1 million the year before. Source: the 10-K filed with the SEC on Mar 21, 2025. SEC
- What was CHIMERIX INC's free cash flow in fiscal 2024?
- CHIMERIX INC reported free cash flow of -$75.3 million for fiscal 2024 (the year ended Dec 31, 2024), against -$69.2 million the year before. Source: the 10-K filed with the SEC on Mar 21, 2025. SEC
- What are CHIMERIX INC's total assets?
- As of Dec 31, 2024, CHIMERIX INC reported total assets of $146 million, against $212.8 million a year earlier (-31.4%). Source: the 10-K filed with the SEC on Mar 21, 2025. SEC
- What are CHIMERIX INC's total liabilities?
- As of Dec 31, 2024, CHIMERIX INC reported total liabilities of $24.3 million, against $19.7 million a year earlier (+23.2%). Source: the 10-K filed with the SEC on Mar 21, 2025. SEC
- What are CHIMERIX INC's cash and cash equivalents?
- As of Dec 31, 2024, CHIMERIX INC reported cash and cash equivalents of $31 million, against $27.7 million a year earlier (+12.2%). Source: the 10-K filed with the SEC on Mar 21, 2025. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1117480&period_type=annual&limit=5"Information only, not investment advice.